what are the risks of glp 1 drugs Do Benefits GLP-1 OutWeigh the Negatives? Exploring the Side Effects of
Description
Blundell J, Finlayson G, Axelsen M, Flint A, Gibbons C, Kvist T, et al
Research participants using GLP-1 therapy often experience reductions in total cholesterol, LDL (bad) cholesterol, and triglycerides within weeks to months of starting treatment
doi: 10.1186/s12933-022-01474-z
1 Pharmacological treatments such as thiazolidinediones, sulfonylureas, and insulins have major drawbacks, including hypoglycaemia and weight gain
The Food and Drug Administration approved Ozempic in 2017 for adults with Type 2 diabetes
Furthermore recent retrospective evidence suggests that 1.0 mg semaglutide is superior to 3.0 mg liraglutide in management of weight regain following metabolic surgery [46]
